Picture of Star Combo Pharma logo

S66 — Star Combo Pharma News Story

0.000.00%
au flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapContrarian

Brief: Star Combo Pharma Says FY Loss From Ordinary Activities Attributable $1.7 Mln

Aug 28 (Reuters) - Star Combo Pharma Ltd  S66.AX :
    * FY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE $1.7 MILLION
VERSUS LOSS OF $1.6 MILLION
    * FY REVENUE FROM ORDINARY ACTIVITIES $21.6 MILLION, UP
98.1%
    * EXPECT 2020 WILL DELIVER "STRONG" REVENUE GROWTH AND
EARNINGS

Source text https://bit.ly/2ZqPicN
Further company coverage:  S66.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Star Combo Pharma

See all news